[
  {
    "ts": null,
    "headline": "Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2025 Update",
    "summary": "Fisher Asset Management's 13F portfolio grew from ~$231B to ~$252B in Q2 2025. Click here to read more about the trades and holdings in the portfolio.",
    "url": "https://finnhub.io/api/news?id=56de5e09f1b0932814f7d0569bd9fec38384cffa4afcbb6be4df991a558ee1cd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755638912,
      "headline": "Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2025 Update",
      "id": 136433308,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "Fisher Asset Management's 13F portfolio grew from ~$231B to ~$252B in Q2 2025. Click here to read more about the trades and holdings in the portfolio.",
      "url": "https://finnhub.io/api/news?id=56de5e09f1b0932814f7d0569bd9fec38384cffa4afcbb6be4df991a558ee1cd"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=eddbcec53c55b0b411cec95409283347e09ec77ab75a11cd1e9d916342347730",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755608402,
      "headline": "Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know",
      "id": 136430229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=eddbcec53c55b0b411cec95409283347e09ec77ab75a11cd1e9d916342347730"
    }
  },
  {
    "ts": null,
    "headline": "ISRG's International Push for Ion: Strategic Bet or Overstretch?",
    "summary": "Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.",
    "url": "https://finnhub.io/api/news?id=a1605658b6c738e6d40843c862c28b2e3ca2a2fc610ce866614e1bc59a9d3423",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755607560,
      "headline": "ISRG's International Push for Ion: Strategic Bet or Overstretch?",
      "id": 136430085,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.",
      "url": "https://finnhub.io/api/news?id=a1605658b6c738e6d40843c862c28b2e3ca2a2fc610ce866614e1bc59a9d3423"
    }
  },
  {
    "ts": null,
    "headline": "CMR Surgical hires Chris O’Hara to drive US robot expansion",
    "summary": "O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization last fall for its Versius system.",
    "url": "https://finnhub.io/api/news?id=cfa5394dff8de697623a5f6fba4afe3fa1401cb2fee9c9e827a245924faf2f52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755604513,
      "headline": "CMR Surgical hires Chris O’Hara to drive US robot expansion",
      "id": 136430231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization last fall for its Versius system.",
      "url": "https://finnhub.io/api/news?id=cfa5394dff8de697623a5f6fba4afe3fa1401cb2fee9c9e827a245924faf2f52"
    }
  },
  {
    "ts": null,
    "headline": "Evercore ISI Lowered the Firm’s PT on Intuitive Surgical (ISRG), Kept an In Line Rating",
    "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On July 23, Evercore ISI lowered the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $550 to $535, while keeping an In Line Rating on the stock. The rating follows the company’s fiscal second-quarter earnings call […]",
    "url": "https://finnhub.io/api/news?id=f2d8a6285dbeb0b26b7479b4a70ebb84a49cd542b8131b399a4779c861e8c352",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755573346,
      "headline": "Evercore ISI Lowered the Firm’s PT on Intuitive Surgical (ISRG), Kept an In Line Rating",
      "id": 136417016,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On July 23, Evercore ISI lowered the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $550 to $535, while keeping an In Line Rating on the stock. The rating follows the company’s fiscal second-quarter earnings call […]",
      "url": "https://finnhub.io/api/news?id=f2d8a6285dbeb0b26b7479b4a70ebb84a49cd542b8131b399a4779c861e8c352"
    }
  }
]